Insights into the AVA™ Emulation System: Ushering in a New Era of Human-Relevant Drug Discovery
Emulate official blog RSS · 行業原文收錄 · 來源發佈：Wed Aug 27 2025 20:53:46 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 07:04:42 GMT+0000 (Coordinated Universal Time)
已保存的原文節選
By Jim Corbett, CEO, Emulate Drug discovery is at a crossroads. With nearly 90% of clinical trial candidates failing to reach FDA approval, the need for more predictive, human-relevant models has never been greater. That’s why Emulate recently launched the AVA Emulation System , the first self-contained Organ-on-a-Chip workstation designed to bring scale, reproducibility, and accessibility to this
以上為帶出處的原文節選，完整內容請閱讀原始鏈接。自動收錄與主題分類不等於事實核驗。